Acadian Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $321K | Buy |
+8,929
| New | +$321K | ﹤0.01% | 1222 |
|
|
2025
Q1 | – | Sell |
-10,944
| Closed | -$278K | – | 1789 |
|
|
2024
Q4 | $278K | Buy |
+10,944
| New | +$278K | ﹤0.01% | 1193 |
|
|
2024
Q3 | – | Sell |
-9,516
| Closed | -$250K | – | 2304 |
|
|
2024
Q2 | $250K | Buy |
+9,516
| New | +$250K | ﹤0.01% | 1378 |
|
|
2024
Q1 | – | Sell |
-142,790
| Closed | -$4.01M | – | 1750 |
|
|
2023
Q4 | $4.01M | Buy |
142,790
+36,427
| +34% | +$1.02M | 0.02% | 513 |
|
|
2023
Q3 | $2.88M | Buy |
106,363
+59,596
| +127% | +$1.62M | 0.01% | 590 |
|
|
2023
Q2 | $1.44M | Buy |
46,767
+43,625
| +1,388% | +$1.34M | 0.01% | 790 |
|
|
2023
Q1 | $113K | Buy |
+3,142
| New | +$113K | ﹤0.01% | 1370 |
|
|
2022
Q3 | – | Sell |
-24,571
| Closed | -$1.03M | – | 1820 |
|
|
2022
Q2 | $1.03M | Buy |
+24,571
| New | +$1.03M | 0.01% | 808 |
|
|
2021
Q1 | – | Sell |
-782
| Closed | -$39K | – | 2288 |
|
|
2020
Q4 | $39K | Sell |
782
-2,679
| -77% | -$134K | ﹤0.01% | 1999 |
|
|
2020
Q3 | $146K | Buy |
+3,461
| New | +$146K | ﹤0.01% | 1559 |
|